Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor
Author:
Funder
Agency for Healthcare Research and Quality
Publisher
Elsevier BV
Subject
Psychiatry and Mental health
Reference12 articles.
1. A consensus statement on the use of ketamine in the treatment of mood disorders;Sanacora;JAMA Psychiat,2017
2. A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders;Wilkinson;Am J Psychiatry,2017
3. Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: a report of two cases;Bartova;Eur Neuropsychopharmacol,2015
4. Ketamine induction and monoamine oxidase inhibitors;Doyle;J Clin Anesth,1990
5. Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital;Wilkinson;J Clin Psychiatry,2018
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preoperative management of medications for psychiatric disorders;Panminerva Medica;2024-09
2. Preoperative management of medications for psychiatric disorders;PANMINERVA MED;2024
3. Pyrazoline Derivatives as Promising MAO-A Targeting Antidepressants: An Update;Current Topics in Medicinal Chemistry;2024-02
4. Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2022-12
5. Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression: A Systematic Literature Review and Case Series;J CLIN PSYCHIAT;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3